[Form 4] Celanese Corporation Insider Trading Activity
Mark Christopher Murray, reported as an officer (SVP - Acetyls) of Celanese Corporation (CE), acquired 2,017 shares of Celanese common stock on 08/14/2025 at a reported price of $41.83 per share.
Rhea-AI Filing Summary
Mark Christopher Murray, reported as an officer (SVP - Acetyls) of Celanese Corporation (CE), acquired 2,017 shares of Celanese common stock on 08/14/2025 at a reported price of $41.83 per share. Following the transaction the filing reports 17,000 shares beneficially owned in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions are reported on this filing.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider purchase reported; transaction size and holdings disclosed.
The Form 4 documents a straightforward open-market purchase by a company officer of 2,017 shares at $41.83 on 08/14/2025, increasing reported direct beneficial ownership to 17,000 shares. There are no derivative instruments disclosed. The filing appears complete for the reported non-derivative transaction and was executed by an attorney-in-fact on 08/18/2025.
TL;DR: Disclosure complies with Section 16 format; shows single-class stock acquisition.
The reporting person is identified with role details (SVP - Acetyls) and relationship checked as an officer. The report lists the transaction code 'P' for an acquisition and the resulting direct ownership amount. No amendments or derivative activity are noted within the submission. From a governance and disclosure perspective, the Form 4 provides the standard information required for this type of insider purchase.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,017 | $41.83 | $84K |
AI-generated analysis. How Rhea-AI works. Not financial advice.